Regulus Therapeutics Statistics

Total Valuation

RGLS has a market cap or net worth of $115.93 million. The enterprise value is $41.20 million.

Market Cap	115.93M
Enterprise Value	41.20M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

RGLS has 66.24 million shares outstanding. The number of shares has increased by 197.18% in one year.

Current Share Class	66.24M
Shares Outstanding	66.24M
Shares Change (YoY)	+197.18%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	2.07%
Owned by Institutions (%)	57.33%
Float	48.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.50
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.98, with a Debt / Equity ratio of 0.01.

Current Ratio	10.98
Quick Ratio	10.10
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-316.71

Financial Efficiency

Return on equity (ROE) is -95.00% and return on invested capital (ROIC) is -61.47%.

Return on Equity (ROE)	-95.00%
Return on Assets (ROA)	-54.42%
Return on Invested Capital (ROIC)	-61.47%
Return on Capital Employed (ROCE)	-65.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	10.88

Taxes

In the past 12 months, RGLS has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.38% in the last 52 weeks. The beta is 1.41, so RGLS's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	-33.38%
50-Day Moving Average	1.31
200-Day Moving Average	1.55
Relative Strength Index (RSI)	72.30
Average Volume (20 Days)	2,223,172

Short Selling Information

The latest short interest is 2.04 million, so 3.08% of the outstanding shares have been sold short.

Short Interest	2.04M
Short Previous Month	2.24M
Short % of Shares Out	3.08%
Short % of Float	4.20%
Short Ratio (days to cover)	6.49

Income Statement

Revenue	n/a
Gross Profit	-35.37M
Operating Income	-50.04M
Pretax Income	-35.39M
Net Income	-46.36M
EBITDA	-49.69M
EBIT	-50.04M
Earnings Per Share (EPS)	-$0.82

Full Income Statement

Balance Sheet

The company has $75.78 million in cash and $1.06 million in debt, giving a net cash position of $74.72 million or $1.13 per share.

Cash & Cash Equivalents	75.78M
Total Debt	1.06M
Net Cash	74.72M
Net Cash Per Share	$1.13
Equity (Book Value)	76.41M
Book Value Per Share	1.17
Working Capital	74.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.67 million and capital expenditures -$340,000, giving a free cash flow of -$42.01 million.

Operating Cash Flow	-41.67M
Capital Expenditures	-340,000
Free Cash Flow	-42.01M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RGLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-197.18%
Shareholder Yield	-197.18%
Earnings Yield	-39.99%
FCF Yield	-36.24%

Analyst Forecast

The average price target for RGLS is $11.80, which is 574.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.80
Price Target Difference	574.29%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 29, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 29, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2